Evidence map›Paper›PMID 26968639›Full record

ArticleThe journals of gerontology. Series B, Psychological sciences and social sciences2017

Exportation and Validation of Latent Constructs for Dementia Case Finding in a Mexican American Population-based Cohort.

Donald R Royall, Raymond F Palmer, Kyriakos S Markides

Registry-linked trialOpen access · bronzeAbstract readComparative StudyValidation Study
In one paragraph

Article in The journals of gerontology. Series B, Psychological sciences and social sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02878538 (An N of One Clinical Trial to Pilot the Feasibility of Using the Iron-Chelator Deferiprone on Mild Cognitive Impairment), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02878538 early_phase1withdrawnnot on this mapstarted 2018, after this paper: background citation

An N of One Clinical Trial to Pilot the Feasibility of Using the Iron-Chelator Deferiprone on Mild Cognitive Impairment

TypeinterventionalSponsorThe University of Texas Health Science Center at San AntonioRan2018 to 2023Enrolled0ConditionsMild Cognitive ImpairmentArmsDeferiprone, Placebo phase
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Donald R RoyallDepartment of Psychiatry, University of Texas Health Science Center, San Antonio.
Raymond F PalmerDepartment of Family and Community Medicine, University of Texas Health Science Center, San Antonio.
Kyriakos S MarkidesDivision of Social and Behavioral Sciences, Department of Preventive Medicine and Community Health, University of Texas Medical Branch, Galveston.
The University of Texas Health Science Center at San Antonio · US

Funding

LONGITUDINAL STUDY OF MEXICAN AMERICAN ELDERLY HEALTHR01AG010939 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI MARKIDES, KYRIAKOS S · 1992 to 2022
$14.6M
San Antonio OAIC - Research Education Component (REC)P30AG044271 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Adam Salmon, Elena Volpi · 2015 to 2026
$14.1M
NIA NIH HHS P30 AG044271NIA NIH HHS R01 AG010939
6 · The paper itself

Abstract

backgroundThe latent variable "δ" has been validated as a dementia phenotype. δ can be extracted from Spearman's general intelligence factor "g" in any data set that contains measures of cognition and instrumental activities of daily living (IADL). We used δ composites ("d-scores") to estimate the prevalence of dementia in the Hispanic Established Population for Epidemiological Studies in the Elderly (H-EPESE).

methodδ was constructed from Mini-Mental State Examination, a clock-drawing task (CLOX), and IADL. δ's H-EPESE factor weights were validated in the well-characterized Texas Alzheimer's Research and Care Consortium (TARCC). Optimal thresholds for the discrimination between "Alzheimer's disease" (AD) versus normal controls (NCs) were determined by receiver operating characteristic curve. Those thresholds were used to estimate the prevalence of dementia in H-EPESE.

resultsEach δ homolog fits its source's data well. d-scores were strongly associated with Clinical Dementia Rating scale Sum of Boxes (r = .74-.85, all p < .001], and accurately distinguished AD cases from NCs, in both Mexican Americans (MAs) and non-Hispanic Whites (NHWs) [c = 0.94-0.96]. The TARCC MA threshold estimated the prevalence of dementia at 21.4% in H-EPESE. The NHW threshold estimated the prevalence of dementia at 21.0%.

conclusionsIt is possible to export δ composites from populations to well-characterized cohorts for validation.

Indexed as

Activities of Daily LivingAgedAged, 80 and overAlzheimer DiseaseCohort StudiesCross-Sectional StudiesDepressive DisorderFemaleHumansIntelligenceLongitudinal StudiesMaleMental Status ScheduleMexican AmericansMiddle AgedNeuropsychological TestsAgingCognitionDementiaFunctional statusg

Identifiers

PMID26968639
PMCPMC5927021
OpenAlexW2340024685

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.